My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Biogen Inc

Recent news which mentions Biogen Inc

< Previous 1 2 3 4 Next >
Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
Tags stocks Markets Whirlpool Corp
From CNBC.com News
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
Tags US: News Biogen Inc Pharmaceuticals
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags 5 Things to Know Eli Lilly and Co Investing
From CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
Tags Business News Alzheimer's disease Business
From CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
Tags Business Biotechnology Science
From CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
Tags Business News Law and Regulation Alzheimer's disease
From CNBC.com News
Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more
Tags TG Therapeutics Inc First Solar Inc Stock markets
From CNBC.com News
Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more
Tags Alibaba Group Holding Ltd Business Bloom Energy Corp
From CNBC.com News
Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
Tags Biogen Inc Pharmaceuticals Eisai Co Ltd
From CNBC.com News
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
Tags Biogen Inc US: News World News
From CNBC.com News
Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more
Tags JD/Com Inc Steel Dynamics Inc Freeport/McMoRan Inc
From CNBC.com News
FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval
Tags Breaking News: Business Science Biotechnology
From CNBC.com News
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
Tags Eisai Co Ltd Health & Science US Economy
From CNBC.com News
Jim Cramer expects defensive stocks to be resilient as debt ceiling talks drag on
Tags Mad Money U/S/ Markets Stock markets
From CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags Politics Alzheimer's disease Policy
From CNBC.com News
Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more
Tags Markets stocks Pearson PLC
From CNBC.com News
Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments
Tags Coronavirus Disease outbreaks World News
From CNBC.com News
Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
Tags Biotech and Pharmaceuticals U/S/ Economy Quest Diagnostics Inc
From CNBC.com News
Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says
Tags Biogen Inc US: News Eisai Co Ltd
From CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
Tags Eli Lilly and Co Biogen Inc US: News
From CNBC.com News
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
Tags Health care industry Companies Health & Science
From CNBC.com News
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
Tags Biotech and Pharmaceuticals Breaking news Breaking News: Business
From CNBC.com News
Eli Lilly says experimental Alzheimer's drug reduces brain plaque in early study
Tags Companies Eisai Co Ltd Health & Science
From CNBC.com News
FDA advisors reject Biogen's ALS drug for rare and aggressive form of the disease
Tags Health & Science Health care industry Biotechnology
From CNBC.com News
FDA staff says Biogen's ALS drug may have a 'clinical benefit' on a rare form of the disease
Tags Biotech and Pharmaceuticals Breaking news Breaking News: Business
From CNBC.com News
Veterans' Health will cover Alzheimer's treatment Leqembi for some patients
Tags US: News Biogen Inc Health care industry
From CNBC.com News
FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July
Tags Biogen Inc US: News US Economy
From CNBC.com News
Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi
Tags US: News Biogen Inc World News
From CNBC.com News
Stocks making the biggest moves midday: Deere, Airbnb, AutoNation, Moderna and more
Tags Bio Rad Laboratories Inc Breaking News: Markets Stock markets
From CNBC.com News
Senators call on Medicare to offer broad coverage of Alzheimer's treatments as public pressure grows
Tags US: News Biogen Inc Health care industry
From CNBC.com News
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.